#Tetrahydrobiopterin
New US research:

Dysregulation of tetrahydrobiopterin metabolism in #MyalgicEncephalomyelitis / #ChronicFatigueSyndrome by pentose phosphate pathway

Free fulltext:
journals.sagepub.com/doi/10.1177/...

#MEcfs #CFS #PwME
August 19, 2024 at 6:52 PM
Tetrahydrobiopterin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Friend or Foe?

[OI = orthostatic intolerance]

www.mdpi.com/2218-273X/15...

Image is from the Science for ME latest update

#MEcfs #CFS #PwME
January 12, 2025 at 11:23 PM
Structural analysis of apo and UDP-bound tetrahydrobiopterin glucosyltransferase revealed features at the active-site pocket differing from other retaining GT-B glycosyltransferases #Tetrahydrobiopterin #GTBGlycosyltransferase #Crystallography doi.org/10.1107/S205...
December 16, 2025 at 2:06 PM
Neue Publikation:
L-Citrullin und Tetrahydrobiopterin als Ernährungsintervention bei peripherer arterieller Verschlusskrankheit: Eine randomisierte Phase-II-Studie (CIPER-Studie)

1/3
February 28, 2025 at 4:40 PM
it's autosomal dominant with reduced penetrance, which means that not everyone with the gene is symptomatic, but everyone who has it has a break in the pipeline which makes dopamine, often around the tetrahydrobiopterin cofactor.
September 1, 2025 at 5:24 PM
You are listening. You are learning about QDPR autosomal recessive tetrahydrobiopterin-deficient hyperphenylalaninemia due to quinoid dihydropteridine reductase deficiency
May 2, 2025 at 11:03 AM
Tetrahydrobiopterin—A Cause of Orthostatic Imbalance in People with ME/CFS (2024)

"traced the origin of low blood pressure and orthostatic imbalance in patients with ME/CFS by dissecting the metabolic pathway responsible for making tetrahydrobiopterin—the pentose phosphate pathway"
#MECFS
#NEISvoid
Tetrahydrobiopterin—A Cause of Orthostatic Imbalance in People with ME/CFS - Solve ME/CFS Initiative
Dr. Avik Roy is the chief scientific officer and chief of neurobiology at the Simmaron Research Institute, a nonprofit organization researching ways to treat patients with ME/CFS or Long Covid. In 202...
solvecfs.org
September 1, 2024 at 1:24 PM
I didn't know you were a carrier for quinoid dihydropteridine reductase autosomal recessive tetrahydrobiopterin-deficient hyperhenylalaninemia due to quinoid dihydropteridine reductase deficiency. What's that like
May 2, 2025 at 9:27 AM
🧬Science Wednesdays

A signaling pathway is a series of events on and within a cell that conveys information and leads to a specific function or response.

Learn more about signaling pathways and a study investigating the tetrahydrobiopterin (BH4) pathway: ow.ly/2i6A50XbPsq

#pwME #pwLC #BH4
Signaling pathway - Open Medicine Foundation
Learn about signaling pathways and why studying pathways abnormalities is important in ME/CFS research.
ow.ly
October 15, 2025 at 2:58 PM
Plain Language Summary
Tetrahydrobiopterin (BH4) metabolism is tightly regulated in a healthy individual. Recently, our research showed that BH4 level is upregulated in the plasma samples of ME/CFS patients with orthostatic intolerance. While investigating the molecular mechanism, our current study
November 18, 2024 at 11:55 PM
Dysregulation of tetrahydrobiopterin metabolism in myalgic encephalomyelitis/chronic fatigue syndrome by pentose phosphate pathway: journals.sagepub.com/doi/full/10....
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
November 18, 2024 at 11:52 PM
Tetrahydrobiopterin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Friend or Foe? — Rahman et al.

www.s4me.info/threads/tetr...

4/12
Tetrahydrobiopterin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Friend or Foe?, 2025, A. F. M. Towheedur Rahman et al
Published January 10, 2025 Abstract: Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS) is a chronic multisystem disease characterized by...
www.s4me.info
January 13, 2025 at 9:49 AM
I'm doing my best to interpret the Wikipedia page on hyperphenylalaninemia & tetrahydrobiopterin but I'm not an expert in biochem.

...

"The typical cost of treating a patient with Kuvan [tetrahydrobiopterin replacement] is US$100,000 per year." Jesus H. Christ. For-profit pharma is cancer. [3/4]
August 23, 2024 at 11:23 PM